Literature DB >> 12801908

Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm.

Lei Zheng1, Ulrich Baumann, Jean-Louis Reymond.   

Abstract

Functional expression of catalytic antibodies in the cytoplasm of E. coli is potentially of great interest in searching for new catalysts by genetic selection. Herein, a catalytic antibody single chain Fv (ScFv) 14D9, which catalyzes a highly enantioselective protonation, was expressed as a NusA fusion protein under the T7 promoter. A functional disulfide-containing ScFv fusion protein was obtained in the oxidizing environment of bacterial cytoplasm. The 14D9 ScFv could not be overexpressed alone without NusA fusion. The highly soluble NusA protein most likely retards aggregate formation of ScFv and indirectly supports correct folding and disulfide bridge formation in the fusion construct ScFv-NusA. The ScFv-NusA fusion product shows highly enantioselective, specific, hapten inhibited catalytic activity comparable to its parent monoclonal antibody, 14D9. The NusA fusion method might be generally helpful for functional antibody expression in vivo and for the new development of biocatalysts by genetic selection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801908     DOI: 10.1093/jb/mvg074

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  An efficient one-step site-directed and site-saturation mutagenesis protocol.

Authors:  Lei Zheng; Ulrich Baumann; Jean-Louis Reymond
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

Review 2.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

3.  Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.

Authors:  Erik Kvam; Michael R Sierks; Charles B Shoemaker; Anne Messer
Journal:  Protein Eng Des Sel       Date:  2010-04-08       Impact factor: 1.650

4.  Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli.

Authors:  Hans Peter Sørensen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2005-01-04       Impact factor: 5.328

5.  Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.

Authors:  Kenichi Miyata; Satoshi Takagi; Shigeo Sato; Hiroshi Morioka; Kiyotaka Shiba; Tamiko Minamisawa; Miho Takami; Naoya Fujita
Journal:  Cancer Med       Date:  2014-08-16       Impact factor: 4.452

6.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

7.  Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens.

Authors:  Hirra Hussain; Edward A McKenzie; Andrew M Robinson; Neill A Gingles; Fiona Marston; Jim Warwicker; Alan J Dickson
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-28       Impact factor: 4.813

Review 8.  Specific in vivo knockdown of protein function by intrabodies.

Authors:  Andrea L J Marschall; Stefan Dübel; Thomas Böldicke
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

Review 9.  Prokaryotic expression of antibodies and affibodies.

Authors:  Luis Angel Fernández
Journal:  Curr Opin Biotechnol       Date:  2004-08       Impact factor: 9.740

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.